REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

Conditions

• CLL, Relapsed
• CLL, Refractory
• Bruton Tyrosine Kinase Inhibitor
• Small Lymphocytic Leukemia

Sponsor

French Innovative Leukemia Organisation

Collaborators

• [object Object]